Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Experimental Hematology & Oncology|June 1, 2017
Clinical implications of c-maf expression in plasma cells from patients with multiple myelomaGuoQing Wei, LiJun Wang, HanJin Yang, et al.
SAGE Open Medicine|June 9, 2021
Hemorrhage and venous thromboembolism in critically ill patients with COVID-19Chenyang Qiu, Tong Li, Guoqing Wei, et al.
Bone Marrow Transplantation|December 7, 2018
A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemiaYongxian Hu, Jiasheng Wang, Guoqing Wei, et al.
International Journal of Hematology|September 10, 2025
Sequential intrathoracic injection and intravenous infusion of BCMA CAR-T cells in a patient with relapsed/refractory primary plasma cell leukemiaWei Han, Shuyang Wang, Mingming Zhang, et al.
Experimental Hematology & Oncology|March 5, 2024
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignanciesLinqin Wang, Yuqi Lv, Linghui Zhou, et al.
Cytotherapy|December 10, 2022
Cytokine profiles are associated with prolonged hematologic toxicities after B-cell maturation antigen targeted chimeric antigen receptor-T-cell therapyLinqin Wang, Ruimin Hong, Linghui Zhou, et al.
Cell Transplantation|September 5, 2023
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell LymphomaXueer Xu, Cheng Zu, Mingming Zhang, et al.
Frontiers in Oncology|November 18, 2021
Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant RelapseLijuan Ding, Yiyun Wang, Ruimin Hong, et al.
Eclinicalmedicine|May 30, 2023
Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I studyYongxian Hu, Cheng Zu, Mingming Zhang, et al.
Leukemia Research|September 24, 2009
Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experienceWeiyan Zheng, Guoqing Wei, Xiujin Ye, et al.
Pageof 18